Zobrazeno 1 - 10
of 72
pro vyhledávání: '"Javier Garcia-Corbacho"'
Autor:
Nuria Ribelles, Javier Pascual, Laura Galvez-Carvajal, Sofía Ruiz-Medina, Javier Garcia-Corbacho, Jose Carlos Benitez, Maria Emilia Dominguez-Recio, Esperanza Torres, Lucia Oliva, Manuel Zalabardo, Antonio Rueda, Emilio Alba
Publikováno v:
JCO Global Oncology, Vol , Iss 10 (2024)
PURPOSEData from population-based studies have shown an increased incidence of certain types of neoplasms in patients younger than 50 years (early-onset cancer [EOC]); however, little information is derived from other real-world data sources. In a no
Externí odkaz:
https://doaj.org/article/9cade2a971ce489fb67e02e30bfa5fa6
Autor:
Iain R. Macpherson, Pavlina Spiliopoulou, Saeed Rafii, Matilde Saggese, Richard D. Baird, Javier Garcia-Corbacho, Antoine Italiano, Jacques Bonneterre, Mario Campone, Nicola Cresti, John Posner, Yousuke Takeda, Akinori Arimura, James Spicer
Publikováno v:
Breast Cancer Research, Vol 22, Iss 1, Pp 1-9 (2019)
Abstract Background Epertinib (S-222611) is a potent reversible inhibitor of HER2, EGFR and HER4. This trial evaluated the safety, tolerability, pharmacokinetics and antitumour activity of daily oral epertinib combined with trastuzumab (arm A), with
Externí odkaz:
https://doaj.org/article/1caffbf612894f738efaee3a4d3d13dc
Autor:
Fara Brasó-Maristany, Miriam Sansó, Nuria Chic, Débora Martínez, Blanca González-Farré, Esther Sanfeliu, Lucio Ghiglione, Esther Carcelero, Javier Garcia-Corbacho, Marcelo Sánchez, Dolors Soy, Pedro Jares, Vicente Peg, Cristina Saura, Montserrat Muñoz, Aleix Prat, Ana Vivancos
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
The immune checkpoint inhibitor atezolizumab is approved for PD-L1-positive triple-negative breast cancer (TNBC). However, no activity of atezolizumab in PD-L1-negative TNBC has been reported to date. Here, we present the case study of a woman with T
Externí odkaz:
https://doaj.org/article/ed4b45258e414194b8958445070c4092
Autor:
Hendrik-Tobias Arkenau, Marta Gil-Martin, Fiona Thistlethwaite, Karen A. Autio, Patrick A. Ott, Johanna Bendell, Patricia LoRusso, Valentina Boni, Alexander Spira, Javier Garcia-Corbacho, Mark Stroh, Elisabeth G.E. De Vries, Ferry A.L.M. Eskens, Nataliya Uboha, Manreet Randhawa, Greg Durm, Alison L. Hannah
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss 7 (2021)
Background Probody® therapeutics are antibody prodrugs that are activated in the tumor microenvironment by tumor-associated proteases, thereby restricting the activity to the tumor microenvironment and minimizing ‘off-tumor’ toxicity. We report
Externí odkaz:
https://doaj.org/article/e9995b5c481945709e7709fd5db97be9
Autor:
Omid Hamid, Fiona Thistlethwaite, Johanna Bendell, Ruth Plummer, Patrick A Ott, Rachel E Sanborn, Karen A Autio, Valentina Boni, Elisabeth GE de Vries, Javier Garcia-Corbacho, Daniel C Cho, Mark Stroh, Lawrence Lu
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss 7 (2021)
Background Probody® therapeutics are antibody prodrugs designed to be activated by tumor-associated proteases. This conditional activation restricts antibody binding to the tumor microenvironment, thereby minimizing ‘off-tumor’ toxicity. Here, w
Externí odkaz:
https://doaj.org/article/bede17be06fa40b884678abba71d0fbe
Autor:
Valentina Boni, Mary J. Fidler, Hendrik-Tobias Arkenau, Alexander Spira, Funda Meric-Bernstam, Nataliya Uboha, Rachel E. Sanborn, Randy F. Sweis, Patricia LoRusso, Misako Nagasaka, Javier Garcia-Corbacho, Shadia Jalal, James J. Harding, Stella K. Kim, Iris H.C. Miedema, Danielle J. Vugts, Marc C. Huisman, Gerben J.C. Zwezerijnen, Guus A.M.S. van Dongen, C. Willemien Menke van der Houven van Oordt, Song Wang, Tam Dang, Ivan A. Zein, Olga Vasiljeva, Susan K. Lyman, Virginia Paton, Alison Hannah, Joyce F. Liu
Publikováno v:
Clinical Cancer Research, 28(10), 2020-2029. American Association for Cancer Research Inc.
Purpose: Praluzatamab ravtansine (CX-2009) is a conditionally activated Probody drug conjugate (PDC) comprising an anti-CD166 mAb conjugated to DM4, with a protease-cleavable linker and a peptide mask that limits target engagement in normal tissue an
Autor:
Alexander Spira, Henry Castro, Song Wang, Alison L. Hannah, Mark Stroh, Valentina Boni, Javier Garcia-Corbacho, Rachel E. Sanborn, Jordi Rodon, Hirva Mamdani, Nehal Lakhani, Navid Hafez, Anthony El-Khoueiry, Melissa Johnson
Supplementary methods and figures
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2b00c3ef1eee989efec695eba00efac4
https://doi.org/10.1158/1078-0432.22480559
https://doi.org/10.1158/1078-0432.22480559
Autor:
Alexander Spira, Henry Castro, Song Wang, Alison L. Hannah, Mark Stroh, Valentina Boni, Javier Garcia-Corbacho, Rachel E. Sanborn, Jordi Rodon, Hirva Mamdani, Nehal Lakhani, Navid Hafez, Anthony El-Khoueiry, Melissa Johnson
Patient Cases
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a22150d3ee3ed4964314be410460d4dc
https://doi.org/10.1158/1078-0432.22480550
https://doi.org/10.1158/1078-0432.22480550
Autor:
Alexander Spira, Henry Castro, Song Wang, Alison L. Hannah, Mark Stroh, Valentina Boni, Javier Garcia-Corbacho, Rachel E. Sanborn, Jordi Rodon, Hirva Mamdani, Nehal Lakhani, Navid Hafez, Anthony El-Khoueiry, Melissa Johnson
Supplementary Data is word format for production
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b9e2b6977bcf5628fdc3faadb8402ae0
https://doi.org/10.1158/1078-0432.22480556.v1
https://doi.org/10.1158/1078-0432.22480556.v1
Autor:
Sabine C. Linn, Carlos Caldas, Javier Cortès, William Gallagher, Cristina Saura, René Bernards, Aurelia de Vries Schultink, Margaret Schot, Petra Nederlof, Else Platte, Hilde Rosing, José-Manuel Perez-Garcia, Emma Beddowes, Maurizio Callari, Harm van Tinteren, Sanjeev Kumar, Constanza Linossi, Erik van Werkhoven, Greig Dougall, Anne-Laure Vallier, Javier Garcia-Corbacho, Ingrid A.M. Mandjes, Mariette Schrier, Meiling Gao, Karin Beelen, Mafalda Oliveira, Annelot G.J. van Rossum, Richard D. Baird
Pharmacokinetics: Z-endoxifen levels per taselisib dose level
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0b8c3ce186a1e98a096fd80e837ef085
https://doi.org/10.1158/1078-0432.22471986.v1
https://doi.org/10.1158/1078-0432.22471986.v1